NEJM This Week — July 13, 2023
Featuring articles on the cardiovascular safety of testosterone therapy, targeting BRAF in papillary craniopharyngioma, prehospital tranexamic acid for severe trauma, survival with CAR T cells in relapsed lymphoma, and osimertinib in EGFR-mutated non–small-cell lung cancer; a review article on cutaneous electroanalgesia for pain relief; a case report of a man with eyelid swelling; and Perspective articles on Medicare’s plan for drug-price negotiation, on the National Health Service in the United Kingdom, and on hospital problems.
